Table of Contents > Interactions & Depletions > Active hexose correlated compound (AHCC) Print

Active hexose correlated compound (AHCC)



Interactions

AHCC/Drug Interactions:
  • Antineoplastic agentsAntineoplastic agents: Based on animal study, AHCC has been shown to reduce the adverse effects and enhance the antitumor effects of cisplatin (13).
  • Antidiabetic agentsAntidiabetic agents: Based on human study, AHCC may decrease glycosylated hemoglobin and blood sugar levels (3). Theoretically, concurrent use of AHCC with antidiabetic agents may have added blood sugar-lowering effects and increase the risk of hypoglycemia.
  • ImmunosuppressantsImmunosuppressants: Based on animal (4) and human study (5; 6), AHCC may modulate immunologic response. Theoretically, AHCC may interfere with the effects of immunosuppressants.

AHCC/Herb/Supplement Interactions:
  • AntineoplasticsAntineoplastics: Based on animal study, AHCC has been shown to reduce the adverse effects and enhance the antitumor effects of cisplatin (13).
  • AntioxidantsAntioxidants: Based on animal study, AHCC may suppress oxidative stress and the activity of ornithine decarboxylase (7). Based on in vitro study, AHCC may decrease levels of iNOS mRNA (8). Theoretically, concurrent use of AHCC and other antioxidants may have additive effects.
  • HypoglycemicsHypoglycemics: Based on human study, AHCC may decrease glycosylated hemoglobin and blood sugar levels (3). Theoretically, concurrent use of AHCC with hypoglycemic agents may have added blood sugar-lowering effects and increase the risk of hypoglycemia.
  • ImmunostimulantsImmunostimulants: Based on animal (4) and human study (5; 6), AHCC may modulate immunologic response. Theoretically, concurrent use of AHCC and immunostimulants may have additive effects.
  • ImmunosuppressantsImmunosuppressants: Based on animal (4) and human study (5; 6), AHCC may modulate immunologic response. Theoretically, AHCC may interfere with the effects of immunosuppressants.

AHCC/Food Interactions:
  • Insufficient available evidence.

AHCC/Lab Interactions:
  • Blood glucoseBlood glucose: Based on human study, AHCC may decrease glycosylated hemoglobin and blood sugar levels (3).
  • Immune panelImmune panel: Based on animal (4) and human study (5; 6), AHCC may modulate immunologic response. Based on mouse study, levels of interleukin-12, tumor necrosis factor-alpha, and interleukin-6 may activate early with AHCC supplementation (4).
  • Liver function testsLiver function tests: Based on human study, AHCC treatment was associated with slightly better values of certain hepatic enzymes in hepatic carcinoma patients (9).

Copyright © 2011 Natural Standard (www.naturalstandard.com)


The information in this monograph is intended for informational purposes only, and is meant to help users better understand health concerns. Information is based on review of scientific research data, historical practice patterns, and clinical experience. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions.

Search Site